SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-17-003809
Filing Date
2017-01-17
Accepted
2017-01-17 10:40:14
Documents
1
Period of Report
2017-01-12

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3958
  Complete submission text file 0001209191-17-003809.txt   5371
Mailing Address C/O ADVENTRX PHARMACEUTICALS, INC. 12390 EL CAMINO REAL, SUITE 150 SAN DIEGO CA 92130
Business Address
Vetticaden Santosh (Reporting) CIK: 0001386932 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35902 | Film No.: 17529607

Mailing Address 10220 SOUTH 51ST STREET SUITE 2 PHOENIX AZ 85044
Business Address 10220 SOUTH 51ST STREET SUITE 2 PHOENIX AZ 85044 602-910-2617
Insys Therapeutics, Inc. (Issuer) CIK: 0001516479 (see all company filings)

IRS No.: 510327886 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations